| abstract |
The present invention relates to quinoline and quinoxaline compounds that inhibit platelet-derived growth factor and / or tyrosine kinase Lck, pharmaceutical compositions containing these compounds, and the use of these compounds to treat a patient suffering from or susceptible to diseases and conditions involving cell differentiation proliferation, extracellular matrix production or mediator release, and / or T cell activation and proliferation. The international application has been published ste with the international search report. |